1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with daunorubicin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckstrøm, KJ; Bettaïeb, A; Laurent, G; Lautier, D; Lehne, G; Maestre, N; Plo, I | 1 |
Grazide, S; Jaffrézou, JP; Laurent, G; Lerouge, S; Terrisse, AD | 1 |
Bao, W; Chen, BA; Cheng, J; Ding, JH; Gao, C; Gao, F; Liang, YQ; Song, HH; Sun, YY; Wang, F; Wang, J; Wang, XM; Wu, WW; Xia, GH; Yin, L; Zhao, G | 1 |
Bao, W; Chen, B; Cheng, J; Ding, J; Gao, C; Gao, F; Sun, Y; Wang, J; Wang, X; Xia, G; Yin, L; Zhao, G | 1 |
4 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and daunorubicin
Article | Year |
---|---|
Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells.
Topics: Acute Disease; Antigens, CD; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ceramides; Daunorubicin; Drug Interactions; Gangliosides; Glucosylceramides; Humans; Lactosylceramides; Leukemia, Myeloid; Morpholines; Phosphorylation; Sphingosine; Tumor Cells, Cultured; Vincristine | 2002 |
Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glucosyltransferases; Glycosylation; HL-60 Cells; Humans; Leukemia, Myeloid; Morpholines; Protective Agents; U937 Cells | 2004 |
[Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Topics: Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; K562 Cells; Morpholines | 2010 |
Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Humans; K562 Cells; Leukemia; Morpholines | 2011 |